TY - JOUR T1 - Characterization of type 2N von Willebrand disease using molecular and phenotypic analysis JO - Blood Coagulation & Fibrinolysis UR - http://dx.doi.org/10.1097/00001721-199504000-00079 PY - 1995/04/01 AU - Nesbitt IM AU - Guilliatt AM AU - Goodeve AC AU - Preston FE AU - Peake IR ED - DO - DOI: 10.1097/00001721-199504000-00079 PB - Ovid Technologies (Wolters Kluwer Health) VL - 6 IS - 2 SP - 178 EP - 178 Y2 - 2025/07/05 ER -